Question

A patient is scheduled for a Whipple procedure. In which of the following situations is staging laparoscopy NOT recommended?

• A. CA 19-9 level up to 50 U/mL
• B. Tumors located in the body or tail of the pancreas
• C. Large tumors greater than 3 cm
• D. When CT scan findings are inconclusive

Hint:

Indications for Staging Laparoscopy in Pancreatic Adenocarcinoma:
- Body/tail lesions (higher rate of peritoneal spread than head lesions).
- Very high CA 19-9 ($>$ 150 U/mL).
- Large tumor size ($>$ 3 cm).
- Borderline resectable disease.

Answer 1

The Correct Option is A

Concept:
Staging laparoscopy is utilized in pancreatic cancer to identify radiographically occult peritoneal metastases or superficial liver micrometastases, preventing unnecessary morbid laparotomies.
Explanation:
• Routine staging laparoscopy for all pancreatic cancers is no longer universally practiced. It is selectively recommended for patients deemed at high risk for occult disseminated disease.

• High-risk features that warrant a staging laparoscopy include: tumors located in the body or tail of the pancreas (Option B), large primary tumors (typically $>$ 3 cm, Option C), inconclusive imaging findings requiring direct visualization (Option D), and markedly elevated tumor markers (e.g., CA 19-9 $>$ 150-200 U/mL).

• A slightly elevated or normal CA 19-9 level (e.g., up to 50 U/mL, where normal is $<$ 37 U/mL) indicates a lower tumor burden and a significantly lower risk of occult peritoneal spread.

• In such low-risk cases, the yield of staging laparoscopy is poor, and proceeding directly to laparotomy for the Whipple procedure is appropriate, making it "not recommended" as an independent prior step.
Final Answer:
Staging laparoscopy is generally deferred in patients with low-risk features, such as a marginally elevated CA 19-9 (up to 50 U/mL), as the likelihood of finding occult metastasis is minimal.